| Kumar, Nagi B. |
H. Lee Moffitt Cancer Ctr & Res Inst
United States |
Phase II Clinical trial of GTC in Men on Active Surveillance |
5R01CA235032-06 |
Howard L. Parnes, M.D. |
| Cohn, Barbara A |
Public Health Institute
United States |
Discriminatory Mechanisms in Early-Onset and Lethal Prostate Cancer |
5R01CA264519-05 |
Howard L. Parnes, M.D. |
| Kim, Hyung L |
Cedars-Sinai Medical Center
United States |
Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer |
5R01CA280060-03 |
Howard L. Parnes, M.D. |
| Bedrosian, Isabelle |
University Of Tx Md Anderson Can Ctr
United States |
Chimeric RNA driven neopeptide vaccine for prevention of breast cancer in germline BRCA1/2 carriers |
1UG3CA290454-01A1 |
Altaf Mohammed, Ph.D. |
| Hutson, Alan David |
Roswell Park Cancer Institute Corp
United States |
Cancer Immunoprevention Network (CIP-Net) Resource Coordinating Center |
1U24CA305623-01 |
Altaf Mohammed, Ph.D. |
| Demehri, Shadmehr |
Massachusetts General Hospital
United States |
Immunosurveillance of breast glands with oncogenic germline mutations |
5UG3CA290300-02 |
Altaf Mohammed, Ph.D. |
| Cao, Shugeng |
University Of Hawaii At Hilo
United States |
Discovery of novel natural TEAD inhibitors for the chemoprevention of liver tumors |
5UG3CA290375-02 |
Altaf Mohammed, Ph.D. |
| Shirwan, Haval |
University Of Missouri-Columbia
United States |
Developing a novel agonist of CD137 for cancer immunoprevention |
5UG3CA290305-02 |
Altaf Mohammed, Ph.D. |
| Dickinson, Sally E |
University Of Arizona
United States |
Investigating novel targets for topical immunoprevention of keratinocytic skin cancer |
1UG3CA290443-01A1 |
Altaf Mohammed, Ph.D. |
| Zi, Xiaolin |
University Of California-Irvine
United States |
Nautral products for targeting Skp2 in cancer interception |
5UG3CA290368-02 |
Altaf Mohammed, Ph.D. |
